SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX
NEW YORK, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AN2 Therapeutics, Inc. (“AN2” or the “Company”) (NASDAQ: ANTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646 …